Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | CDC-like kinase 4 | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | protein kinase | 0.0155 | 1 | 1 |
Entamoeba histolytica | casein kinase, putative | 0.0155 | 1 | 0.5 |
Loa Loa (eye worm) | CK1/CK1/CK1-A protein kinase | 0.0155 | 1 | 1 |
Trypanosoma cruzi | casein kinase, putative | 0.0155 | 1 | 1 |
Echinococcus granulosus | casein kinase I delta | 0.0155 | 1 | 1 |
Trypanosoma cruzi | casein kinase, delta isoform, putative | 0.0152 | 0.9619 | 0.9619 |
Echinococcus multilocularis | casein kinase I gamma | 0.0124 | 0.6066 | 0.6066 |
Echinococcus multilocularis | casein kinase i | 0.0155 | 1 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0155 | 1 | 1 |
Plasmodium falciparum | casein kinase 1 | 0.0155 | 1 | 1 |
Trypanosoma cruzi | casein kinase, delta isoform, putative | 0.0155 | 1 | 1 |
Echinococcus granulosus | casein kinase I gamma | 0.0124 | 0.6066 | 0.6066 |
Echinococcus granulosus | casein kinase I delta | 0.0155 | 1 | 1 |
Echinococcus granulosus | casein kinase I alpha | 0.0155 | 1 | 1 |
Trypanosoma cruzi | casein kinase, putative | 0.0155 | 1 | 1 |
Loa Loa (eye worm) | protein kinase domain-containing protein | 0.0124 | 0.6066 | 0.6066 |
Trypanosoma cruzi | casein kinase, putative | 0.0155 | 1 | 1 |
Echinococcus granulosus | casein kinase I alpha | 0.0155 | 1 | 1 |
Trichomonas vaginalis | CK1 family protein kinase | 0.0155 | 1 | 1 |
Giardia lamblia | Kinase, CK1 Casein kinase | 0.0155 | 1 | 1 |
Entamoeba histolytica | casein kinase 1, putative | 0.0155 | 1 | 0.5 |
Echinococcus multilocularis | casein kinase I alpha | 0.0155 | 1 | 1 |
Trichomonas vaginalis | CK1 family protein kinase | 0.0155 | 1 | 1 |
Loa Loa (eye worm) | CK1/CK1/CK1-D protein kinase | 0.0155 | 1 | 1 |
Echinococcus multilocularis | casein kinase I delta | 0.0155 | 1 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0124 | 0.6066 | 0.6066 |
Trypanosoma brucei | casein kinase I, isoform 2 | 0.0155 | 1 | 1 |
Toxoplasma gondii | casein kinase I | 0.0155 | 1 | 1 |
Echinococcus multilocularis | casein kinase I alpha | 0.0155 | 1 | 1 |
Trichomonas vaginalis | CK1 family protein kinase | 0.0155 | 1 | 1 |
Trypanosoma cruzi | casein kinase, putative | 0.0155 | 1 | 1 |
Trypanosoma cruzi | casein kinase, putative | 0.0155 | 1 | 1 |
Echinococcus multilocularis | casein kinase I alpha | 0.0155 | 1 | 1 |
Plasmodium vivax | casein kinase 1, putative | 0.0155 | 1 | 1 |
Onchocerca volvulus | 0.0155 | 1 | 1 | |
Echinococcus granulosus | casein kinase I alpha | 0.0155 | 1 | 1 |
Echinococcus granulosus | casein kinase i | 0.0155 | 1 | 1 |
Brugia malayi | Protein kinase domain containing protein | 0.0124 | 0.6066 | 0.6066 |
Brugia malayi | casein kinase I | 0.0155 | 1 | 1 |
Loa Loa (eye worm) | casein kinase | 0.0121 | 0.5684 | 0.5684 |
Loa Loa (eye worm) | CK1/CK1/CK1-A protein kinase | 0.0155 | 1 | 1 |
Leishmania major | casein kinase, putative | 0.0155 | 1 | 1 |
Echinococcus multilocularis | casein kinase I delta | 0.0155 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 2.3188 uM | PUBCHEM_BIOASSAY: Confirmation Assay for Inhibitors of CDC-like Kinase 4 (Kinase-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1379, AID1770, AID1983, AID1997, AID2710, AID488872, AID488883, AID488887, AID493206, AID504421, AID504424, AID504427, AID504428, AID504429, AID504430] | ChEMBL. | No reference |
Potency (functional) | 20.6665 uM | PUBCHEM_BIOASSAY: Assay for Inhibitors of Dual-Specificity Tyrosine-(Y)-Phosphorylation Regulated Kinase 1A (Kinase-Glo assay). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1770, AID1997, AID488872, AID488883, AID488887, AID493206] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.